Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.37B | 15.37B | 14.55B | 15.78B | 13.69B | 10.95B |
Gross Profit | 3.98B | 4.71B | 1.63B | 4.62B | 3.86B | 3.44B |
EBITDA | 313.70M | 313.70M | 642.63M | 826.90M | 955.19M | 1.01B |
Net Income | -627.80M | -836.00M | -383.96M | -87.70M | 68.26M | 145.23M |
Balance Sheet | ||||||
Total Assets | 14.98B | 14.98B | 14.90B | 14.81B | 14.03B | 13.62B |
Cash, Cash Equivalents and Short-Term Investments | 109.60M | 109.60M | 161.00M | 308.20M | 314.68M | 348.06M |
Total Debt | 5.95B | 5.95B | 5.09B | 5.10B | 4.75B | 4.93B |
Total Liabilities | 9.88B | 9.88B | 8.73B | 8.74B | 8.01B | 7.66B |
Stockholders Equity | 5.21B | 5.21B | 6.01B | 6.05B | 5.98B | 5.87B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -800.10M | -432.20M | -317.60M | 402.19M | 548.15M |
Operating Cash Flow | 0.00 | 202.80M | 375.70M | 257.20M | 830.76M | 824.60M |
Investing Cash Flow | 0.00 | -648.70M | -503.50M | -249.80M | -431.08M | -118.15M |
Financing Cash Flow | 0.00 | 414.60M | 51.40M | -7.60M | -530.48M | -749.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | 2.02B | 20.52 | 11.98% | ― | 0.00% | 0.00% | |
68 Neutral | 1.74B | 16.60 | 3.91% | 8.04% | -76.65% | -76.77% | |
60 Neutral | 6.41B | 75.71 | 5.10% | ― | 2.99% | 45.22% | |
54 Neutral | 4.50B | 30.68 | 3.40% | ― | 30.63% | 0.00% | |
45 Neutral | ₹3.63B | ― | ― | 10.07% | -35.05% | ||
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Kanoria Chemicals & Industries Ltd has announced the publication of advertisements in newspapers regarding its 65th Annual General Meeting, including details on e-voting facilities. This announcement is part of the company’s compliance with regulatory requirements, ensuring transparency and accessibility for its stakeholders.